Unravelling protein-protein interactions between complement factor H and C-reactive protein using a multidisciplinary strategy
- PMID: 20658973
- DOI: 10.1042/BST0380894
Unravelling protein-protein interactions between complement factor H and C-reactive protein using a multidisciplinary strategy
Abstract
Experimental studies of protein-protein interactions are very much affected by whether the complexes are fully formed (strong, with nanomolar dissociation constants) or partially dissociated (weak, with micromolar dissociation constants). The functions of the complement proteins of innate immunity are governed by the weak interactions between the activated proteins and their regulators. Complement is effective in attacking pathogens, but not the human host, and imbalances in this process can lead to disease conditions. The inherent complexity in analysing complement interactions is augmented by the multivalency of its main regulator, CFH (complement factor H), for its physiological or pathophysiological ligands. The unravelling of such weak protein-protein or protein-ligand interactions requires a multidisciplinary approach. Synchrotron X-ray solution scattering and constrained modelling resulted in the determination of the solution structure of CFH and its self-associative properties, whereas AUC (analytical ultracentrifugation) identified the formation of much larger CFH multimers through the addition of metals such as zinc. The ligands of CFH, such as CRP (C-reactive protein), also undergo self-association. The combination of X-rays and AUC with SPR (surface plasmon resonance) proved to be essential to identify CRP self-association and revealed how CFH interacts with CRP. We show that CRP unexpectedly binds to CFH at two non-contiguous sites and explain its relevance to age-related macular degeneration.
Similar articles
-
Multiple interactions of complement Factor H with its ligands in solution: a progress report.Adv Exp Med Biol. 2010;703:25-47. doi: 10.1007/978-1-4419-5635-4_3. Adv Exp Med Biol. 2010. PMID: 20711705 Review.
-
Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations.J Biol Chem. 2010 Jan 8;285(2):1053-65. doi: 10.1074/jbc.M109.044529. Epub 2009 Oct 22. J Biol Chem. 2010. PMID: 19850925 Free PMC article.
-
Complement factor H-ligand interactions: self-association, multivalency and dissociation constants.Immunobiology. 2012 Feb;217(2):281-97. doi: 10.1016/j.imbio.2011.10.003. Epub 2011 Oct 28. Immunobiology. 2012. PMID: 22137027 Review.
-
Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands.Front Immunol. 2014 Mar 31;5:126. doi: 10.3389/fimmu.2014.00126. eCollection 2014. Front Immunol. 2014. PMID: 24744754 Free PMC article. Review.
-
C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration.Br J Ophthalmol. 2011 Sep;95(9):1323-30. doi: 10.1136/bjo.2010.199216. Epub 2011 Jun 1. Br J Ophthalmol. 2011. PMID: 21633121 Free PMC article.
Cited by
-
C-reactive protein: a target for therapy to reduce inflammation.Front Immunol. 2023 Jul 26;14:1237729. doi: 10.3389/fimmu.2023.1237729. eCollection 2023. Front Immunol. 2023. PMID: 37564640 Free PMC article. Review.
-
Zinc binding to the Tyr402 and His402 allotypes of complement factor H: possible implications for age-related macular degeneration.J Mol Biol. 2011 May 13;408(4):714-35. doi: 10.1016/j.jmb.2011.03.006. Epub 2011 Mar 17. J Mol Biol. 2011. PMID: 21396937 Free PMC article.
-
Structural and molecular changes in the aging choroid: implications for age-related macular degeneration.Eye (Lond). 2017 Jan;31(1):10-25. doi: 10.1038/eye.2016.216. Epub 2016 Oct 7. Eye (Lond). 2017. PMID: 27716746 Free PMC article. Review.
-
Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces.J Biol Chem. 2018 Nov 2;293(44):17166-17187. doi: 10.1074/jbc.RA118.004767. Epub 2018 Sep 14. J Biol Chem. 2018. PMID: 30217822 Free PMC article.
-
CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation.Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E696-E704. doi: 10.1073/pnas.1718059115. Epub 2018 Jan 8. Proc Natl Acad Sci U S A. 2018. PMID: 29311295 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous